CRISPR Technology: Global Markets
Report Scope
This report on CRISPR technology provides market projections for 2029 and analyzes the market for CRISPR technology by application and end user. Applications covered include drug development, agriculture, diagnostics and others. End users include biotechnology and pharmaceutical companies, academics and government research institutes, and contract research organizations.
Report Includes
32 data tables and 61 additional tables
An analysis of the global market for CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology
Analyses of the global market trends, with data from 2021-2022, estimates for 2023, forecast for 2024, and projected CAGRs through 2029
Discussion of the market potential for CRISPR technology
Estimate of the market size and a revenue forecast for the global CRISPR technology market, and a corresponding market share analysis by application, end user, and region
Discussion of the major market dynamics, regulations, industry challenges, and macroeconomic factors that will affect the demand for CRISPR technology market over the next five years
A look at the recent breakthrough in CRISPR-Cas9 genome editing technology, and how it has propelled the rapid growth in genetic engineering and advanced pharmacological research
A comparative study on CRISPR with TALE and ZFN nuclease as a gene editing tool and discussion on its higher adaptability over other nucleases
Review of the patent filings and research publications for innovations in the CRISPR-Cas9 genome editing technology
A discussion on ESG challenges and ESG practices of the industry participants
A look at the proprietary technologies and strategic alliances of the companies best positioned in the CRISPR market
Analysis of the industry structure, competitive landscape, clinical trials, ongoing research activities, and the impact of COVID-19
Company profiles of the major players, including Merck KGaA, Thermo Fisher Scientific, Beam Therapeutics, CRISPR Therapeutics and Danaher Corp.
Companies Mentioned
AGILENT TECHNOLOGIES INC.
BEAM THERAPEUTICS
CARIBOU BIOSCIENCES INC.
CRISPR THERAPEUTICS
DANAHER CORP.
EDITAS MEDICINE
GENSCRIPT
INTELLIA THERAPEUTICS INC.
LONZA
MERCK KGAA
THERMO FISHER SCIENTIFIC INC.
- Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Summary
- Chapter 2 Market Overview
- Genome Editing
- CRISPR
- Introduction
- Components of CRISPR
- Mechanism of Action
- CRISPR Gene Editing Workflow
- Advantages and Disadvantages of CRISPR Technology
- Pricing Analysis
- PESTLE Analysis
- Porter's Five Forces Analysis
- Regulatory Landscape, by Type
- Human
- Gene Drives
- Agriculture
- Animals
- Regulatory Landscape, by Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
- Chapter 3 Market Dynamics
- Market Dynamics Snapshot
- Market Drivers
- Rising Incidence of Chronic Diseases
- Prevalence of Genetic Disorders
- Government and Private Funding
- Market Restraints
- Alternative Technologies
- Market Opportunities
- Increase in the Number of Applications
- Market Challenges
- Complex and Evolving Regulatory Landscape
- High Cost of CRISPR-based Therapy
- Chapter 4 Emerging Technologies and Developments
- Emerging Technologies
- In Vivo Delivery of CRISPR
- Improved Cas Variants
- Artificial Intelligence
- Clinical Trials Analysis
- Clinical Trials Analysis, by Type of Study
- Clinical Trials Analysis, by Status
- Clinical Trials Analysis, by Phase
- Clinical Trials
- Patent Analysis
- Patents, by Year
- Patents, by Top Applicant
- Patents, by Top Owner
- Patents, by Jurisdiction
- Intellectual Property Disputes and Patent Issues
- Chapter 5 Market Segmentation Analysis
- Segmentation Breakdown
- Market Breakdown, by Application
- Drug Development
- Agriculture
- Diagnostics
- Other Applications
- Market Breakdown, by End User
- Biotech and Pharmaceutical Companies
- Academics and Government Research Institutes
- Contract Research Organizations
- Geographic Breakdown
- Market Analysis, by Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
- Chapter 6 Competitive Intelligence
- Market Analysis
- Strategic Analysis
- Chapter 7 Sustainability in CRISPR Technology: An ESG Perspective
- Introduction to ESG
- Sustainability in CRISPR Technology: An ESG Perspective
- Key ESG Issues
- CRISPR Technology ESG Performance Analysis
- Environmental Performance
- Social Performance
- Governance Performance
- Concluding Remarks from BCC
- Chapter 8 Appendix
- Methodology
- References
- Abbreviations
- Company Profiles
- AGILENT TECHNOLOGIES INC.
- BEAM THERAPEUTICS
- CARIBOU BIOSCIENCES INC.
- CRISPR THERAPEUTICS
- DANAHER CORP.
- EDITAS MEDICINE
- GENSCRIPT
- INTELLIA THERAPEUTICS INC.
- LONZA
- MERCK KGAA
- THERMO FISHER SCIENTIFIC INC.
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook